newsfilter
← Latest News
PR Newswire·

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

Messenger RNA Diagnostic/Treatment Paradigm VANCOUVER, BC, Nov. 9, 2021 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE:NOVA) (FSE: HN3Q) (OTCQB:NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocyb